Orderappai has launched Menu Order AI, an AI-powered app helping GLP-1 users and health-conscious diners find suitable restaurant meals. The app scans menus instantly, highlighting high-protein, low-carb, and GLP-1-friendly options with personalized meal modifications.
-- Orderappai has announced the official launch of Menu Order AI on the Apple App Store, addressing a critical challenge faced by the nearly 12% of U.S. adults who use GLP-1 medication and struggle to identify suitable meals when dining out or ordering delivery. The app represents the first AI-powered solution developed specifically for GLP-1 users, who often experience nausea and other side effects triggered by certain foods, making restaurant choices stressful and uncertain.
More details can be found at https://apps.apple.com/us/app/menu-order-ai-find-glp1-meals/id6753690910
Menu Order AI uses on-device artificial intelligence to scan restaurant menus in seconds, instantly highlighting GLP-1-friendly meals, high-protein options, and low-carbohydrate choices that support appetite control and blood sugar stability. The app has earned a 4.4 out of 5-star rating on the Apple App Store, reflecting early user satisfaction with its practical approach to navigating dietary restrictions in real-world dining scenarios. The app also launched on the Google Play Store on January 2, 2026, making it compatible with Android devices as well.
The app comes with a Smart Tweaks feature that provides personalized meal modifications tailored to individual health goals. It suggests adjustments such as choosing grilled preparations instead of fried, requesting lettuce wraps in place of bread, or asking for dressing on the side. These practical recommendations empower GLP-1 users to confidently adapt menu items at any restaurant without sacrificing flavor or dining experience.
One user testimonial captures the emotional and practical relief the app delivers: "I'm on a GLP-1 medication, and eating at restaurants used to feel stressful. Menu Order AI instantly shows me high-protein and GLP-1-friendly meals at every place I go. I've never felt more confident ordering." This feedback underscores how the app transforms dining from a source of anxiety into an experience marked by confidence and control.
Menu Order AI functions across multiple dining contexts, including sit-down restaurants, delivery platforms, and on-the-go situations. Its launch aligns with broader trends in the restaurant industry, which is adapting to the rising prevalence of GLP-1 users and health-conscious diners. Industry reports indicate that restaurants are adjusting menus and portion sizes in response to customers who find rich or oversized meals unappealing or physically uncomfortable.
Many GLP-1 users report that fatty, calorie-dense foods no longer appeal to them, while smaller appetites and altered taste preferences reshape their dining habits. Orderappai's solution meets this industry-wide shift by providing a tool that bridges the gap between evolving consumer needs and existing restaurant offerings.
For more information, visit https://apps.apple.com/us/app/menu-order-ai-find-glp1-meals/id6753690910
Contact Info:
Name: Melissa Butler
Email: Send Email
Organization: Orderappai
Address: Boston Ma, Needham, Massachusetts 02492, United States
Website: https://www.orderappai.com/
Source: PressCable
Release ID: 89181623
In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.